Quick Answer
Glucotrack, Inc. reported Operating Income of -$16.09 million for fiscal year 2025.
Glucotrack, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$16.09M | -10.6% |
| 2024 | -$14.55M | -104.8% |
| 2023 | -$7.10M | -60.3% |
| 2022 | -$4.43M | -9.7% |
| 2021 | -$4.04M | -29.0% |
| 2020 | -$3.13M | -189.3% |
| 2019 | $3.51M | +153.6% |
| 2018 | -$6.54M | -161.8% |
| 2017 | $10.58M | +287.0% |
| 2016 | -$5.66M | -21.5% |
| 2015 | -$4.66M | -29.1% |
| 2014 | -$3.61M | -19.1% |
| 2013 | -$3.03M | -9.2% |
| 2012 | -$2.77M | -18.9% |
| 2011 | -$2.33M | -67.8% |
| 2010 | -$1.39M | -18.8% |
| 2009 | -$1.17M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.31M | -32.5% | +10.2% |
| June 30, 2025 | -$4.80M | -6.8% | -37.1% |
| March 31, 2025 | -$3.50M | -18.5% | -7.6% |
| September 30, 2024 | -$3.25M | -46.2% | +27.6% |
| June 30, 2024 | -$4.49M | -280.9% | -52.2% |
| March 31, 2024 | -$2.95M | -129.8% | -32.7% |
| September 30, 2023 | -$2.22M | -139.4% | -88.6% |
| June 30, 2023 | -$1.18M | -5.0% | +8.2% |
- Glucotrack, Inc. showed a decrease of -10.6% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, Glucotrack, Inc.’s operating income has declined by 1274.9% (from -$1.17 million to -$16.09 million).
- The most recent figure is from Glucotrack, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: